Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hyperfine (HYPR) Cash & Equivalents (2020 - 2025)

Hyperfine (HYPR) has disclosed Cash & Equivalents for 6 consecutive years, with $21.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents fell 52.88% year-over-year to $21.6 million, compared with a TTM value of $21.6 million through Sep 2025, down 52.88%, and an annual FY2024 reading of $37.6 million, down 49.93% over the prior year.
  • Cash & Equivalents was $21.6 million for Q3 2025 at Hyperfine, down from $25.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $188.5 million in Q4 2021 and bottomed at $21.6 million in Q3 2025.
  • Average Cash & Equivalents over 5 years is $84.9 million, with a median of $77.4 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents surged 200.75% in 2021, then crashed 52.88% in 2025.
  • Year by year, Cash & Equivalents stood at $188.5 million in 2021, then crashed by 37.68% to $117.5 million in 2022, then plummeted by 36.0% to $75.2 million in 2023, then tumbled by 49.93% to $37.6 million in 2024, then plummeted by 42.72% to $21.6 million in 2025.
  • Business Quant data shows Cash & Equivalents for HYPR at $21.6 million in Q3 2025, $25.4 million in Q2 2025, and $33.1 million in Q1 2025.